Abstract
IntroductionFinding an accurate and convenient biomarker for cancer progression in Barrett's (BE) is of high clinical importance. DNA ploidy abnormalities (DNA-PA) are a reliable predictor of cancer risk in BE,...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have